Bai, Francesca; Mazzitelli, Maria; Silvola, Sofia; Raumer, Francesca; Restell, Umberto; Croce, Davide; Marchetti, Giulia; Cattelan, Anna Maria
(Oxford University Press, 2023-04-02)
OBJECTIVES: Thanks to its long half-life, dalbavancin qualifies as an optimal drug for saving costs. We aimed to assess the cost and effectiveness of dalbavancin versus the standard of care (SoC).
PATIENTS AND METHODS: ...